Chimeric immunoreceptor useful in treating human cancers

Details for Australian Patent Application No. 2007237297 (hide)

Owner City of Hope

Inventors Jensen, Michael

Agent FB Rice

Pub. Number AU-B-2007237297

Parent 2002256390

Filing date 30 November 2007

Wipo publication date 20 December 2007

Acceptance publication date 16 December 2010

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 35/26 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Lymph

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 14/715 (2006.01) Peptides having more than 20 amino acids

C12N 5/0783 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - T cells

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

13 December 2007 Complete Application Filed

20 December 2007 Application Open to Public Inspection

  Published as AU-B-2007237297

16 December 2010 Application Accepted

  Published as AU-B-2007237297

14 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007237298-Deployment system for an endoluminal device

2007237296-Interferons, uses and compositions related thereto